Comprehensive Structure-Activity Profiling of Micheliolide and its Targeted Proteome in Leukemia Cells via Probe-Guided Late-Stage C-H Functionalization

The plant-derived sesquiterpene lactone micheliolide was recently found to possess promising antileukemic activity, including the ability to target and kill leukemia stem cells. Efforts toward improving the biological activity of micheliolide and investigating its mechanism of action have been hindered by the paucity of preexisting functional groups amenable for late-stage derivatization of this molecule. Here, we report the implementation of a probe-based P450 fingerprinting strategy to rapidly evolve engineered P450 catalysts useful for the regio- and stereoselective hydroxylation of micheliolide at two previously inaccessible aliphatic positions in this complex natural product. Via P450-mediated chemoenzymatic synthesis, a broad panel of novel micheliolide analogs could thus be obtained to gain structure-activity insights into the effect of C2, C4, and C14 substitutions on the antileukemic activity of micheliolide, ultimately leading to the discovery of micheliologs with improved potency against acute myelogenic leukemia cells. These late-stage C-H functionalization routes could be further leveraged to generate a panel of affinity probes for conducting a comprehensive analysis of the protein targeting profile of micheliolide in leukemia cells via chemical proteomics analyses. These studies introduce new micheliolide-based antileukemic agents and shed new light onto the biomolecular targets and mechanism of action of micheliolide in leukemia cells. More broadly, this work showcases the value of the present P450-mediated C-H functionalization strategy for streamlining the late-stage diversification and elucidation of the biomolecular targets of a complex bioactive molecule.

Automated summary

By utilizing a probe-based P450 fingerprinting strategy, engineered P450 catalysts were rapidly evolved for the regio- and stereoselective hydroxylation of micheliolide, resulting in a broad panel of novel analogs that provided insights into the structure-activity relationship of micheliolide's antileukemic activity. This approach also allowed for the generation of affinity probes for analyzing the protein targeting profile of micheliolide in leukemia cells through chemical proteomics analyses, leading to the discovery of new micheliolide-based antileukemic agents and an improved understanding of its mechanism of action. The study highlights the value of the P450-mediated C-H functionalization strategy for late-stage diversification and elucidation of biomolecular targets in a complex bioactive molecule.